118 related articles for article (PubMed ID: 7544299)
21. The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets.
Sargeant P; Farndale RW; Sage SO
FEBS Lett; 1993 Jan; 315(3):242-6. PubMed ID: 8422913
[TBL] [Abstract][Full Text] [Related]
22. Calcium entry activated by store depletion in coronary endothelium is promoted by tyrosine phosphorylation.
Sharma NR; Davis MJ
Am J Physiol; 1996 Jan; 270(1 Pt 2):H267-74. PubMed ID: 8769761
[TBL] [Abstract][Full Text] [Related]
23. Capacitative Ca(2+) entry and tyrosine kinase activation in canine pulmonary arterial smooth muscle cells.
Doi S; Damron DS; Horibe M; Murray PA
Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L118-30. PubMed ID: 10645899
[TBL] [Abstract][Full Text] [Related]
24. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle.
Jin N; Siddiqui RA; English D; Rhoades RA
Am J Physiol; 1996 Oct; 271(4 Pt 2):H1348-55. PubMed ID: 8897927
[TBL] [Abstract][Full Text] [Related]
25. Modulation of Ca(2+)-activated K+ channel activity by tyrosine kinase inhibitors in vascular smooth muscle cell.
Xiong Z; Burnette E; Cheung DW
Eur J Pharmacol; 1995 Jul; 290(2):117-23. PubMed ID: 8575525
[TBL] [Abstract][Full Text] [Related]
26. Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases.
Fleming I; Fisslthaler B; Busse R
Circ Res; 1995 Apr; 76(4):522-9. PubMed ID: 7895328
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine phosphorylation as a convergent pathway of heterotrimeric G protein- and rho protein-mediated Ca2+ sensitization of smooth muscle of rabbit mesenteric artery.
Sasaki M; Hattori Y; Tomita F; Moriishi K; Kanno M; Kohya T; Oguma K; Kitabatake A
Br J Pharmacol; 1998 Dec; 125(8):1651-60. PubMed ID: 9886756
[TBL] [Abstract][Full Text] [Related]
28. Evidence for capacitative and non-capacitative Ca2+ entry pathways coexist in A10 vascular smooth muscle cells.
Zhou JG; Qiu QY; Zhang Z; Liu YJ; Guan YY
Life Sci; 2006 Feb; 78(14):1558-63. PubMed ID: 16236332
[TBL] [Abstract][Full Text] [Related]
29. Regulation of vascular and gastric smooth muscle contractility by pervanadate.
Laniyonu A; Saifeddine M; Ahmad S; Hollenberg MD
Br J Pharmacol; 1994 Oct; 113(2):403-10. PubMed ID: 7530569
[TBL] [Abstract][Full Text] [Related]
30. Vanadate-induced contraction of smooth muscle and enhanced protein tyrosine phosphorylation.
Di Salvo J; Semenchuk LA; Lauer J
Arch Biochem Biophys; 1993 Aug; 304(2):386-91. PubMed ID: 7688495
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine kinase-dependent modulation of calcium entry in rabbit colonic muscularis mucosae.
Hatakeyama N; Mukhopadhyay D; Goyal RK; Akbarali HI
Am J Physiol; 1996 Jun; 270(6 Pt 1):C1780-9. PubMed ID: 8764162
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle.
Di Salvo J; Steusloff A; Semenchuk L; Satoh S; Kolquist K; Pfitzer G
Biochem Biophys Res Commun; 1993 Feb; 190(3):968-74. PubMed ID: 8439345
[TBL] [Abstract][Full Text] [Related]
33. Insulin inhibits serotonin-induced Ca2+ influx in vascular smooth muscle.
Kahn AM; Allen JC; Seidel CL; Song T
Circulation; 1994 Jul; 90(1):384-90. PubMed ID: 8026022
[TBL] [Abstract][Full Text] [Related]
34. The role of capacitative Ca2+ influx in the alpha 1B-adrenoceptor-mediated contraction to phenylephrine of the rat spleen.
Burt RP; Chapple CR; Marshall I
Br J Pharmacol; 1995 Oct; 116(4):2327-33. PubMed ID: 8564268
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses.
Murphy CT; Kellie S; Westwick J
Eur J Biochem; 1993 Sep; 216(2):639-51. PubMed ID: 7690703
[TBL] [Abstract][Full Text] [Related]
36. Bradykinin B2 receptor-induced and inositol tetrakisphosphate-evoked Ca2+ entry is sensitive to a protein tyrosine phosphorylation inhibitor in ras-transformed NIH/3T3 fibroblasts.
Hashii M; Nakashima S; Yokoyama S; Enomoto K; Minabe Y; Nozawa Y; Higashida H
Biochem J; 1996 Oct; 319 ( Pt 2)(Pt 2):649-56. PubMed ID: 8912707
[TBL] [Abstract][Full Text] [Related]
37. Ca2+ release and Ca2+ influx in Chinese hamster ovary cells expressing the cloned mouse B2 bradykinin receptor: tyrosine kinase inhibitor-sensitive and- insensitive processes.
Taketo M; Yokoyama S; Kimura Y; Higashida H
Biochim Biophys Acta; 1997 Jan; 1355(1):89-98. PubMed ID: 9030205
[TBL] [Abstract][Full Text] [Related]
38. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets.
Jonas JC; Plant TD; Gilon P; Detimary P; Nenquin M; Henquin JC
Br J Pharmacol; 1995 Feb; 114(4):872-80. PubMed ID: 7773549
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells.
Wheeler-Jones CP; May MJ; Morgan AJ; Pearson JD
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):407-16. PubMed ID: 8615807
[TBL] [Abstract][Full Text] [Related]
40. Actions of 4-chloro-3-ethyl phenol on internal Ca2+ stores in vascular smooth muscle and endothelial cells.
Low AM; Sormaz L; Kwan CY; Daniel EE
Br J Pharmacol; 1997 Oct; 122(3):504-10. PubMed ID: 9351507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
